2024 Q4 FDA Zorbium® Report

animal species# of animals treatedreceive_dateunique_aer_id_numberreaction_veddra_term_codereaction_veddra_term_namereaction_veddra_version
Cat120241003USA-USFDACVM-2024-US-060125116Behavioural disorder NOS18
Cat120241022USA-USFDACVM-2024-US-064513302Diarrhoea18
Cat120241008USA-USFDACVM-2024-US-0626881903Sedation prolonged18
Cat220241003USA-USFDACVM-2024-US-060606116Behavioural disorder NOS18
Cat120241209USA-USFDACVM-2024-US-0737902531Dysphoria18
Cat120241008USA-USFDACVM-2024-US-061197121Agitation18
20241127USA-USFDACVM-2024-US-07224199030Underfilling, Package10
Cat120241219USA-USFDACVM-2024-US-0772352274Dull18
Cat120241219USA-USFDACVM-2024-US-0772882610Panic18
Cat120241002USA-USFDACVM-2024-US-059859116Behavioural disorder NOS18
Cat120241001USA-USFDACVM-2024-US-060172189Decreased heart rate18
20241004USA-USFDACVM-2024-US-06026599031Underfilling, Tubes10
Cat120241018USA-USFDACVM-2024-US-0642391207Not eating18
Cat120241218USA-USFDACVM-2024-US-0762562649Lack of efficacy (ectoparasite) - flea18
20241004USA-USFDACVM-2024-US-06062699031Underfilling, Tubes10
Cat120241216USA-USFDACVM-2024-US-0764532531Dysphoria18
Cat320241216USA-USFDACVM-2024-US-0758302531Dysphoria18
Cat120241112USA-USFDACVM-2024-US-0704252874Urinary tract obstruction/blockage18
Cat120241017USA-USFDACVM-2024-US-064273739Urinary tract disorder NOS18
Cat120241114USA-USFDACVM-2024-US-0705911414Dilated pupils18
Cat320241217USA-USFDACVM-2024-US-0765842531Dysphoria18
Cat320241018USA-USFDACVM-2024-US-064294302Diarrhoea18
Cat220241009USA-USFDACVM-2024-US-0616672190Unclassifiable adverse event18
Cat120241009USA-USFDACVM-2024-US-0643942190Unclassifiable adverse event18
Cat120241122USA-USFDACVM-2024-US-0720361990Limping18
Cat120241027USA-USFDACVM-2024-US-066515855Panting18
Cat220241003USA-USFDACVM-2024-US-0612122190Unclassifiable adverse event18
Cat220241004USA-USFDACVM-2024-US-0614271032Fever18
Cat120241002USA-USFDACVM-2024-US-0618852755Growling18
Cat120241202USA-USFDACVM-2024-US-0732553Application site hair loss18
Cat120241209USA-USFDACVM-2024-US-075021119Restlessness18
Cat120241001USA-USFDACVM-2024-US-0602612022Head bobbing18
Cat120241206USA-USFDACVM-2024-US-0758452Application site alopecia18
Cat120241218USA-USFDACVM-2024-US-0772502Application site alopecia18
Cat220241002USA-USFDACVM-2024-US-0606012531Dysphoria18
Cat120241010USA-USFDACVM-2024-US-0642182520Not urinating18
Cat120241104USA-USFDACVM-2024-US-0703861025Reluctant to move18
Cat120241205USA-USFDACVM-2024-US-074432119Restlessness18
Cat120241001USA-USFDACVM-2024-US-061224679Constricted pupils18
Cat120241020USA-USFDACVM-2024-US-0642641018Lethargy (see also Central nervous system depression in Neurological)18
Cat120241108USA-USFDACVM-2024-US-069039115Anxiety18
Cat120241004USA-USFDACVM-2024-US-061209118Hyperactivity18
Cat120241119USA-USFDACVM-2024-US-0708312874Urinary tract obstruction/blockage18
Cat120241202USA-USFDACVM-2024-US-0733812Application site alopecia18
20241218USA-USFDACVM-2024-US-07584899031Underfilling, Tubes10
Cat120241114USA-USFDACVM-2024-US-070777996Anorexia18
Cat120241107USA-USFDACVM-2024-US-067885189Decreased heart rate18
20241016USA-USFDACVM-2024-US-06297299031Underfilling, Tubes10
Cat120241023USA-USFDACVM-2024-US-064611517Facial swelling (see also Skin)18
Cat120241010USA-USFDACVM-2024-US-061909118Hyperactivity18
Cat120241112USA-USFDACVM-2024-US-0708292531Dysphoria18
20241127USA-USFDACVM-2024-US-07232099031Underfilling, Tubes10
Cat120241018USA-USFDACVM-2024-US-064274654Ataxia18
Cat220241107USA-USFDACVM-2024-US-069008116Behavioural disorder NOS18
Cat120241129USA-USFDACVM-2024-US-073234121Agitation18
Cat120241212USA-USFDACVM-2024-US-0748931967Haematuria18
Cat520241008USA-USFDACVM-2024-US-064249118Hyperactivity18
20241126USA-USFDACVM-2024-US-07205799003Color, Abnormal10
Cat120241209USA-USFDACVM-2024-US-074578855Panting18
Cat120241018USA-USFDACVM-2024-US-064255118Hyperactivity18
Cat120241018USA-USFDACVM-2024-US-0643051414Dilated pupils18
Cat120241206USA-USFDACVM-2024-US-0772681207Not eating18
Cat120241106USA-USFDACVM-2024-US-070319118Hyperactivity18
Cat120241008USA-USFDACVM-2024-US-0617325Application site erythema18
Cat120241205USA-USFDACVM-2024-US-0743571032Fever18
Cat120241114USA-USFDACVM-2024-US-0703291039Lack of efficacy - NOS18
Cat120241030USA-USFDACVM-2024-US-0661541014Hyperthermia18
Cat120241113USA-USFDACVM-2024-US-0703133062Fear/fearful18
Cat120241112USA-USFDACVM-2024-US-0690382Application site alopecia18
Cat120241119USA-USFDACVM-2024-US-0708302531Dysphoria18
Cat120241106USA-USFDACVM-2024-US-0681651018Lethargy (see also Central nervous system depression in Neurological)18
Cat120241004USA-USFDACVM-2024-US-061223984Death18
Cat120241217USA-USFDACVM-2024-US-075843998Decreased appetite18
Cat120241211USA-USFDACVM-2024-US-0756451034Febrile18
Cat120241015USA-USFDACVM-2024-US-062960654Ataxia18
Cat120241015USA-USFDACVM-2024-US-0631521414Dilated pupils18
Cat120241018USA-USFDACVM-2024-US-0643021414Dilated pupils18
Cat120241001USA-USFDACVM-2024-US-0617243Application site hair loss18
Cat120241220USA-USFDACVM-2024-US-0772621915Breathlessness18
Cat120241216USA-USFDACVM-2024-US-0756655Application site erythema18
Cat120241119USA-USFDACVM-2024-US-0721723Application site hair loss18
Cat120241011USA-USFDACVM-2024-US-064198981Death by euthanasia18
Cat120241210USA-USFDACVM-2024-US-074875116Behavioural disorder NOS18
Cat120241024USA-USFDACVM-2024-US-0660901171Laboured breathing18
Cat120241224USA-USFDACVM-2024-US-077429118Hyperactivity18
Cat120241218USA-USFDACVM-2024-US-076092300Stomatitis18
Cat120241021USA-USFDACVM-2024-US-0642961033Elevated temperature18
Human120241015USA-USFDACVM-2024-US-064391453Eye irritation18
Cat120241002USA-USFDACVM-2024-US-061231140Not sleeping18
Cat120241210USA-USFDACVM-2024-US-0748821903Sedation prolonged18
Cat120241024USA-USFDACVM-2024-US-064812118Hyperactivity18
Cat120241107USA-USFDACVM-2024-US-0681251857Unconscious18
Cat220241015USA-USFDACVM-2024-US-0629591021Reduced responses18
Cat220241212USA-USFDACVM-2024-US-0749011207Not eating18
Cat120241023USA-USFDACVM-2024-US-0645052190Unclassifiable adverse event18
Cat120241024USA-USFDACVM-2024-US-0656772776Heavy breathing18
Cat120241003USA-USFDACVM-2024-US-061271116Behavioural disorder NOS18
Cat120241021USA-USFDACVM-2024-US-0643031033Elevated temperature18
Cat120241029USA-USFDACVM-2024-US-066152292Drooling18
Cat120241017USA-USFDACVM-2024-US-064217229Low blood pressure18
Cat120241106USA-USFDACVM-2024-US-068859118Hyperactivity18
Cat120241203USA-USFDACVM-2024-US-0736803108Obtunded18
Cat620241218USA-USFDACVM-2024-US-077244116Behavioural disorder NOS18
Cat120241107USA-USFDACVM-2024-US-069030113Aggression18
Cat120241130USA-USFDACVM-2024-US-072651112Biting -aggression (see also Skin and appendages disorders)18
Cat120241003USA-USFDACVM-2024-US-061191737Urinary retention18
Cat120241125USA-USFDACVM-2024-US-0720641014Hyperthermia18
20241219USA-USFDACVM-2024-US-07601799031Underfilling, Tubes10
Cat120241004USA-USFDACVM-2024-US-0614692531Dysphoria18
Cat120241004USA-USFDACVM-2024-US-061468119Restlessness18
Cat120241210USA-USFDACVM-2024-US-0750092531Dysphoria18
Cat120241106USA-USFDACVM-2024-US-067686119Restlessness18
Cat120241206USA-USFDACVM-2024-US-0737971207Not eating18
Cat120241203USA-USFDACVM-2024-US-074457116Behavioural disorder NOS18
Cat520241106USA-USFDACVM-2024-US-0676931018Lethargy (see also Central nervous system depression in Neurological)18
Cat120241128USA-USFDACVM-2024-US-073671118Hyperactivity18
Cat120241213USA-USFDACVM-2024-US-075003658Recumbency18
Cat120241202USA-USFDACVM-2024-US-0733681074Foaming at the mouth18
Cat120241121USA-USFDACVM-2024-US-0709841414Dilated pupils18
Cat620241010USA-USFDACVM-2024-US-0628621014Hyperthermia18
Cat120241017USA-USFDACVM-2024-US-0646931903Sedation prolonged18
Cat120241203USA-USFDACVM-2024-US-07457515Application site scab18
Cat120241212USA-USFDACVM-2024-US-074897120Excitation18
Cat220241202USA-USFDACVM-2024-US-0736851014Hyperthermia18
Cat120241129USA-USFDACVM-2024-US-072660116Behavioural disorder NOS18
Cat120241220USA-USFDACVM-2024-US-077249452Eye disorder NOS (for Photophobia see neurological)18
Cat120241104USA-USFDACVM-2024-US-067508118Hyperactivity18
Cat120241125USA-USFDACVM-2024-US-0721711207Not eating18
Cat120241113USA-USFDACVM-2024-US-0706121207Not eating18
Cat120241009USA-USFDACVM-2024-US-0617352207Hiding18
20241113USA-USFDACVM-2024-US-06917499031Underfilling, Tubes10
Cat120241202USA-USFDACVM-2024-US-0748641021Reduced responses18
Dog120241016USA-USFDACVM-2024-US-064279129Vocalisation18
Cat120241217USA-USFDACVM-2024-US-0765911033Elevated temperature18
Cat120241122USA-USFDACVM-2024-US-072318118Hyperactivity18
Cat120241206USA-USFDACVM-2024-US-0743622207Hiding18
Cat120241011USA-USFDACVM-2024-US-063026996Anorexia18
Cat120241017USA-USFDACVM-2024-US-0642191414Dilated pupils18
Cat120241014USA-USFDACVM-2024-US-0631073Application site hair loss18
Cat120241028USA-USFDACVM-2024-US-0656752Application site alopecia18
Cat120241007USA-USFDACVM-2024-US-064267738Stranguria18
Cat120241221USA-USFDACVM-2024-US-0774702635Staring18
Cat120241014USA-USFDACVM-2024-US-0629761014Hyperthermia18
20241112USA-USFDACVM-2024-US-06885399031Underfilling, Tubes10
Cat120241018USA-USFDACVM-2024-US-064341118Hyperactivity18
20241007USA-USFDACVM-2024-US-06157499031Underfilling, Tubes10
Cat120241113USA-USFDACVM-2024-US-070460118Hyperactivity18
Cat120241004USA-USFDACVM-2024-US-0614252208Pacing18
Cat120241015USA-USFDACVM-2024-US-0642992531Dysphoria18
Cat120241010USA-USFDACVM-2024-US-0617362046Hyperphosphataemia18
Cat220241106USA-USFDACVM-2024-US-068836116Behavioural disorder NOS18
Cat120241210USA-USFDACVM-2024-US-076024651Falling18
Cat120241021USA-USFDACVM-2024-US-0644193Application site hair loss18
Cat120241104USA-USFDACVM-2024-US-0675871170Breathing difficulty18
Cat120241119USA-USFDACVM-2024-US-0722151207Not eating18
Cat120241113USA-USFDACVM-2024-US-070456720Renal failure18
Cat120241209USA-USFDACVM-2024-US-0758551014Hyperthermia18
Cat120241203USA-USFDACVM-2024-US-074438220Shock18
Cat120241009USA-USFDACVM-2024-US-0627751638Nausea18
Cat120241009USA-USFDACVM-2024-US-062201541Not drinking18
20241223USA-USFDACVM-2024-US-07721899031Underfilling, Tubes10
Cat120241122USA-USFDACVM-2024-US-0712853061Easily startled18
Cat520241216USA-USFDACVM-2024-US-075825415Corneal ulcer18
Cat120241115USA-USFDACVM-2024-US-0708241207Not eating18
Cat120241004USA-USFDACVM-2024-US-0612661032Fever18
Cat120241014USA-USFDACVM-2024-US-063016958Itching18
Cat120241023USA-USFDACVM-2024-US-066513981Death by euthanasia18
Cat220241209USA-USFDACVM-2024-US-0744671014Hyperthermia18
Cat120241001USA-USFDACVM-2024-US-0606002531Dysphoria18
Cat120241212USA-USFDACVM-2024-US-0748812531Dysphoria18
Cat120241107USA-USFDACVM-2024-US-067750118Hyperactivity18
Cat120241023USA-USFDACVM-2024-US-06449931Application site self trauma18
Cat220241004USA-USFDACVM-2024-US-061203660Disorientation18
Cat120241004USA-USFDACVM-2024-US-0614322531Dysphoria18
Cat120241031USA-USFDACVM-2024-US-066521733Frequent urination18
Cat120241015USA-USFDACVM-2024-US-0642401018Lethargy (see also Central nervous system depression in Neurological)18
Cat320241018USA-USFDACVM-2024-US-064729137Polyphagia18